CMS requires all nursing homes to test staff for coronavirus disease 2019; FEMA signals it may end reimbursement for personal protective equipment; CDC issues new exposure testing recommendations.
New CMS guidelines require all nursing homes to test staff for coronavirus disease 2019 (COVID-19), The Hill reports. Any facility refusing to do so could face financial penalties. The requirement comes 6 months after the virus began infecting individuals in the country’s nursing homes, killing tens of thousands of elderly residents. As tests are more widely available now than they were at the pandemic’s onset, all nursing home staff are required to be tested. Staff are also thought to be the main spreaders of the virus in the facilities. Previous guidelines only recommended testing of nursing home staff.
City and state officials are concerned the Federal Emergency Management Agency (FEMA) may be running out of funds to support local COVID-19 responses, just as more supplies are needed for reopening plans, according to The Washington Post. In particular, officials expressed fears the agency may stop reimbursing some purchases of masks, gloves, and other personal protective equipment (PPE). Concerns stemmed from calls made by FEMA in which the agency signaled it may soon rethink how it distributes relief funds. Agency officials have already told cities and states they may have to turn to other federal programs to cover costs, the director of Vermont’s emergency management agency said.
In revised guidance for COVID-19 testing released this week, the CDC said not all close contacts need to be tested after being exposed to an individual with COVID-19, The Washington Post reports. The updated guidance now reads that those exposed to an individual (within 6 feet for at least 15 minutes) who tested positive do not necessarily need a test if they are not experiencing symptoms. Exceptions include vulnerable individuals with underlying health conditions, or if state or local health officials “recommend you take one.” Several experts expressed concern about the revision, as asymptomatic individuals are still responsible for a large proportion of transmissions.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More